510(k) Report

PMA · Approved

Approved

ProVee System for BPH

P250011PMAApproved Dec 9, 2025251-day reviewClass III

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Proverum, Ltd. · MER Stent, Urethral, Prostatic, Permanent Or Semi-Permanent

Approved on Dec 9, 2025 through premarket approval, which rests on the device’s own clinical evidence after a 251-day review.

Decided
Dec 9, 2025
Review
251 days
Class
Class III
Product code
MER
Recalls
None

PMA approvals rest on their own clinical evidence and do not claim a predicate, so this family tree starts here.

P250011 has 5 supplements since 2026: changes to the approved device, its labelling or its manufacturing, each approved separately.

PMA supplements approved per year

2026: 5
2026high 5 (2026) · low 0 (2027)2027
View FIG. 1 as a table
YearSupplements approved
20265
FIG. 1 — Supplements to P250011, 2026–2026Source: FDA PMA database

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA PMA database (decision fields and supplements), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MER? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

Does it have a predicate?

PMA decisions do not claim a predicate device.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All MER devices

MER Stent, Urethral, Prostatic, Permanent Or Semi-Permanent: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · MER

5so far in 2026, the most since 2007

2025: 22026 (partial year): 5
2007high 5 (2026) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MER

Too few MER 510(k)s in any year since 2007 to give a median.

Recalls per year · MER

No recall names MER since 2007.

Adverse event reports per year · MER

1in 2022

2008: 12010: 42013: 12022: 1
2007high 4 (2010) · low 0 (2007)2025

MAUDE reports naming product code MER, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—01
20090—00
20100—04
20110—00
20120—00
20130—01
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—01
20230—00
20240—00
20252—00
20265—0—
Cite this page

510(k) Report. “P250011: ProVee System for BPH.” Lineage record from FDA PMA data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/P250011

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Page last updated Nov 3, 2026